US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Why a ‘rip-off’ degree might be worth the money after all – research study 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations 
Google promotes ‘teacher approved’ apps for kids. Here’s what parents should know 
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 
Japan Posts First Current Account Deficit in 17 Months as Dividend Payments Surge 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Natura Q2 Profit Plunges 92% as Financial Expenses Weigh on Earnings 
A sugar replacement called erythritol found in Splenda and Equal has been linked by a study to blood clotting, stroke, heart attack, and death.
Erythritolused is used to add bulk or sweeten stevia, monkfruit and keto reduced-sugar products.
Lead study author Dr. Stanley Hazen, director of the Center for Cardiovascular Diagnostics and Prevention at the Cleveland Clinic Lerner Research Institute, warned that “the degree of risk was not modest.”
The study, released on Monday in the journal Nature Medicine, found that people with pre-existing risk factors for heart disease, such as diabetes, were twice as likely to have a heart attack or stroke if they had the highest amounts of erythritol in their blood.
According to Hazen, there was an approximately two-fold increased risk for heart attack and stroke for those whose blood level of erythritol was in the top 25 percent as opposed to the lowest 25 percent. It is comparable to the most serious cardiac risk factors, such as diabetes.
Additional lab and animal research presented in the paper revealed that erythritol appeared to be causing blood platelets to clot more readily. Clots can break off and travel to the heart, triggering a heart attack, or to the brain, triggering a stroke.
Dr. Andrew Freeman, director of cardiovascular prevention and wellness at National Jewish Health, a hospital in Denver, said there appears to be a clotting risk from using erythritol, and that it might make sense to limit erythritol in your diet for now.”
Freeman was not involved in the research.
In response to the study, Robert Rankin, executive director of the Calorie Control Council, an industry association, said that “the results of this study are contrary to decades of scientific research showing reduced-calorie sweeteners like erythritol are safe, as evidenced by global regulatory permissions for their use in foods and beverages.”
Rankin added that the results “should not be extrapolated to the general population, as the participants in the intervention were already at increased risk for cardiovascular events.”
